HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiao-Yuan Chu Selected Research

mouse Itch protein

1/2022ITCH facilitates proteasomal degradation of TXNIP in hypoxia- induced lung cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiao-Yuan Chu Research Topics

Disease

7Neoplasms (Cancer)
11/2021 - 02/2005
5Neoplasm Metastasis (Metastasis)
01/2021 - 05/2009
4Carcinoma (Carcinomatosis)
01/2019 - 02/2005
3Hepatocellular Carcinoma (Hepatoma)
11/2021 - 05/2009
1Inflammation (Inflammations)
01/2022
1Hypoxia (Hypoxemia)
01/2022
1Disease Progression
11/2021
1Carcinogenesis
01/2021
1Pathologic Processes
01/2021
1Colonic Neoplasms (Colon Cancer)
01/2020
1Renal Cell Carcinoma (Grawitz Tumor)
12/2018
1Necrosis
12/2018
1Colorectal Neoplasms (Colorectal Cancer)
05/2012
1Lymphatic Metastasis
05/2012

Drug/Important Bio-Agent (IBA)

3RNA (Ribonucleic Acid)IBA
01/2021 - 02/2005
26-methyladenineIBA
11/2021 - 01/2021
2Long Noncoding RNAIBA
11/2021 - 12/2018
2Messenger RNA (mRNA)IBA
01/2021 - 05/2009
2Indicators and Reagents (Reagents)IBA
01/2020 - 03/2013
1diacetyldichlorofluoresceinIBA
01/2022
1mouse Itch proteinIBA
01/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022
1Sorafenib (BAY 43-9006)FDA Link
11/2021
1MethyltransferasesIBA
01/2021
1Biological ProductsIBA
01/2021
1DNA VaccinesIBA
01/2019
1Biomarkers (Surrogate Marker)IBA
12/2018
1ChemokinesIBA
06/2017
1LigandsIBA
06/2017
1Chemokine ReceptorsIBA
06/2017
1Transcription Factors (Transcription Factor)IBA
12/2012
1SurvivinIBA
05/2012
1Matrix Metalloproteinases (MMPs)IBA
05/2012
1ParaffinIBA
05/2009
1Proteins (Proteins, Gene)FDA Link
05/2009

Therapy/Procedure

2Therapeutics
11/2021 - 06/2017
1Immunotherapy
01/2019